GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the scfv fragment of the broadly neutralizing human antibody EDE2 A11

Analyse Crystal structure of the scfv fragment of the broadly neutralizing human… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4UT7
Type
protein
Length
259 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Broadly neutralizing human antibody EDE2 A11
Pockets
1 · best druggability 0.34

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HBroadly neutralizing human antibody EDE2 A11protein14610% helix, 41% strand—
LBroadly neutralizing human antibody EDE2 A11protein1137% helix, 50% strand—

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1780.340.7518empty

Interfaces

1 interface between chains.

  • H–L · 1174 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 4UT7 · Crystal structure of the scfv fragment of the broadly neutralizing human antibody EDE2 A11 · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.